Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2397-768X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy ; volume:6 ; number:1 ; day:22 ; month:9 ; year:2022 ; pages:1-8 ; date:12.2022
npj precision oncology ; 6, Heft 1 (22.9.2022), 1-8, 12.2022
- Creator
-
Louie, Bryan H.
Kato, Shumei
Kim, Ki Hwan
Lim, Hyo Jeong
Okamura, Ryosuke
Eskander, Ramez N.
Botta, Gregory
Patel, Hitendra
Lee, Suzanna
Lippman, Scott M.
Sicklick, Jason K.
Kurzrock, Razelle
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41698-022-00309-0
- URN
-
urn:nbn:de:101:1-2022120921110323111617
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Louie, Bryan H.
- Kato, Shumei
- Kim, Ki Hwan
- Lim, Hyo Jeong
- Okamura, Ryosuke
- Eskander, Ramez N.
- Botta, Gregory
- Patel, Hitendra
- Lee, Suzanna
- Lippman, Scott M.
- Sicklick, Jason K.
- Kurzrock, Razelle
- SpringerLink (Online service)
Other Objects (12)
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Systematic pan-cancer analysis identifies ZBTB11 as a potential pan-cancer biomarker and immunotherapy target in multiple tumor types
Tumor-associated macrophage clusters linked to immunotherapy in a pan-cancer census
A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Pan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer
Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7
Integrated in silico analysis of LRP2 mutations to immunotherapy efficacy in pan-cancer cohort
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Systematic pan-cancer analysis identifies ZBTB11 as a potential pan-cancer biomarker and immunotherapy target in multiple tumor types
Tumor-associated macrophage clusters linked to immunotherapy in a pan-cancer census
A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Pan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer
Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7
Integrated in silico analysis of LRP2 mutations to immunotherapy efficacy in pan-cancer cohort
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Systematic pan-cancer analysis identifies ZBTB11 as a potential pan-cancer biomarker and immunotherapy target in multiple tumor types
Tumor-associated macrophage clusters linked to immunotherapy in a pan-cancer census
A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Pan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer
Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7